Novo Nordisk Current Ratio 2006-2020 | NVO

Current and historical current ratio for Novo Nordisk (NVO) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Novo Nordisk current ratio for the three months ending March 31, 2020 was 1.00.
Novo Nordisk Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $9.33B $9.33B 1.00
2019-12-31 $9.36B $8.84B 1.06
2019-09-30 $9.45B $9.40B 1.01
2019-06-30 $8.84B $8.52B 1.04
2019-03-31 $8.03B $8.33B 0.96
2018-12-31 $9.03B $8.28B 1.09
2018-09-30 $8.45B $7.71B 1.10
2018-06-30 $9.21B $7.87B 1.17
2018-03-31 $8.24B $7.29B 1.13
2017-12-31 $9.13B $7.15B 1.28
2017-09-30 $9.02B $7.13B 1.27
2017-06-30 $8.72B $6.48B 1.35
2017-03-31 $7.98B $7.01B 1.14
2016-12-31 $8.88B $7.05B 1.26
2016-09-30 $7.74B $6.24B 1.24
2016-06-30 $7.99B $6.31B 1.27
2016-03-31 $6.86B $6.08B 1.13
2015-12-31 $8.21B $6.08B 1.35
2015-09-30 $7.68B $5.74B 1.34
2015-06-30 $7.02B $5.72B 1.23
2015-03-31 $6.59B $6.37B 1.04
2014-12-31 $8.25B $6.01B 1.37
2014-09-30 $7.33B $5.35B 1.37
2014-06-30 $6.29B $4.37B 1.44
2014-03-31 $6.34B $4.85B 1.31
2013-12-31 $7.49B $4.31B 1.74
2013-09-30 $7.27B $4.56B 1.59
2013-06-30 $6.40B $4.45B 1.44
2013-03-31 $6.34B $4.54B 1.40
2012-12-31 $6.94B $3.74B 1.86
2012-09-30 $6.87B $4.41B 1.56
2012-06-30 $6.21B $4.12B 1.51
2012-03-31 $6.41B $3.88B 1.65
2011-12-31 $7.40B $3.88B 1.91
2011-09-30 $7.37B $3.87B 1.91
2011-06-30 $7.31B $3.59B 2.04
2011-03-31 $6.51B $3.35B 1.94
2010-12-31 $6.65B $3.29B 2.02
2010-09-30 $5.87B $2.93B 2.00
2010-06-30 $5.78B $3.13B 1.85
2010-03-31 $5.84B $2.89B 2.02
2009-12-31 $6.12B $2.51B 2.44
2009-09-30 $5.95B $2.48B 2.40
2009-06-30 $5.44B $2.28B 2.38
2009-03-31 $5.02B $2.48B 2.03
2008-12-31 $5.73B $2.55B 2.24
2008-09-30 $5.48B $2.49B 2.20
2008-06-30 $5.51B $2.32B 2.38
2008-03-31 $4.98B $2.33B 2.13
2007-12-31 $4.47B $1.96B 2.28
2007-09-30 $4.30B $1.99B 2.16
2007-06-30 $4.15B $1.91B 2.17
2007-03-31 $3.68B $1.88B 1.97
2006-12-31 $3.50B $1.71B 2.05
2006-09-30 $3.51B $1.96B 1.79
2006-06-30 $3.41B $1.72B 1.99
2006-03-31 $3.04B $1.69B 1.80
2005-12-31 $3.27B $1.77B 1.85
2005-09-30 $2.94B $1.51B 1.95
2005-06-30 $2.72B $1.45B 1.87
2005-03-31 $2.84B $1.29B 2.19
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $152.214B $18.296B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.238B 18.65
Roche Holding AG (RHHBY) Switzerland $294.553B 0.00
Pfizer (PFE) United States $213.662B 13.35
Merck (MRK) United States $204.919B 14.63
Novartis AG (NVS) Switzerland $189.756B 14.75
AbbVie (ABBV) United States $163.988B 9.99
Eli Lilly (LLY) United States $146.273B 22.33
AstraZeneca (AZN) United Kingdom $145.417B 28.27
Sanofi (SNY) $128.988B 15.33
GlaxoSmithKline (GSK) United Kingdom $102.323B 13.42
Bayer (BAYRY) Germany $61.403B 8.85
H Lundbeck (HLUYY) Denmark $7.388B 0.00
Innoviva (INVA) United States $1.370B 6.56